Next Article in Journal
Multimodal Imaging Characteristics in Unilateral Occlusive Macular Telangiectasia with Atypical X-Shaped Lesion
Previous Article in Journal
Sequential Changes in Circulating Tumor Cells in the Peripheral Blood of Pancreatic Cancer Patients with Preoperative Chemotherapy Using a New Immunocytology-Based, Light Microscopic CTC Detection Platform
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Total Intramuscular Fat Fraction of Thigh Muscles as a Predictor of Nusinersen Efficacy in Pediatric SMA Type II and III

1
Department of Pediatrics, Kobe University Graduate School of Medicine, 7-5-1, Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan
2
Research Initiative Center, Organization for Research Initiative and Promotion, Tottori University, 86 Nishi-cho, Yonago 683-8503, Japan
3
Department of Radiology, Kobe University Graduate School of Medicine, 7-5-1, Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan
4
Faculty of Rehabilitation, Kobe Gakuin University, 518 Arise, Ikawadani-cho, Nishi-ku, Kobe 651-2180, Japan
*
Author to whom correspondence should be addressed.
Diagnostics 2025, 15(6), 753; https://doi.org/10.3390/diagnostics15060753
Submission received: 12 February 2025 / Revised: 13 March 2025 / Accepted: 16 March 2025 / Published: 17 March 2025
(This article belongs to the Section Clinical Diagnosis and Prognosis)

Abstract

Background/Objectives: Nusinersen is a disease-modifying drug for spinal muscular atrophy (SMA) that improves motor function. However, its effects on the skeletal muscles remain unclear. This study aimed to assess the intramuscular fat fraction in patients with SMA types II and III using muscle magnetic resonance imaging (MRI) and to explore the relationship between muscle tissue, lipid metabolism, and motor function during nusinersen treatment. Methods: This study included seven pediatric patients with SMA types II and III who received nusinersen treatment. Muscle MRIs were performed at three time points. Images of the central thigh were used to measure the cross-sectional area (CSA) and muscle fat area, and the intramuscular fat fraction (IMFF) was calculated. The thigh muscles were categorized into three groups: quadriceps, adductor, and hamstrings. Results: The median (range) of total IMFF for SMA type II and III at T-0, T-2, and T-4 were 18.5 (12.6–48.4), 24.4 (10.1–61.4), and 39.0 (30.0–68.6) % and increased over time. In five patients whose motor function was evaluated, a moderate negative correlation was observed between the changes in the Hammersmith Functional Motor Score Expanded (HSFME) and IMFF (r = −0.51). No significant changes in serum triglyceride or total cholesterol levels were observed during treatment. Conclusions: An increase in IMFF was associated with a decline in motor function. The baseline IMFF score was related to improvements in motor function scores, suggesting that the IMFF of the thigh muscle may serve as a novel, objective, and quantitative skeletal muscle-related biomarker for predicting the effects of nusinersen on muscle tissue.
Keywords: spinal muscular atrophy; muscle magnetic resonance imaging; nusinersen; lipid metabolism; biomarker spinal muscular atrophy; muscle magnetic resonance imaging; nusinersen; lipid metabolism; biomarker

Share and Cite

MDPI and ACS Style

Iketani, K.; Awano, H.; Hashimura, H.; Sonehara, S.; Hanafusa, H.; Nambu, Y.; Nishio, H.; Nozu, K.; Bo, R. Total Intramuscular Fat Fraction of Thigh Muscles as a Predictor of Nusinersen Efficacy in Pediatric SMA Type II and III. Diagnostics 2025, 15, 753. https://doi.org/10.3390/diagnostics15060753

AMA Style

Iketani K, Awano H, Hashimura H, Sonehara S, Hanafusa H, Nambu Y, Nishio H, Nozu K, Bo R. Total Intramuscular Fat Fraction of Thigh Muscles as a Predictor of Nusinersen Efficacy in Pediatric SMA Type II and III. Diagnostics. 2025; 15(6):753. https://doi.org/10.3390/diagnostics15060753

Chicago/Turabian Style

Iketani, Kiiko, Hiroyuki Awano, Hiromi Hashimura, Shoko Sonehara, Hiroaki Hanafusa, Yoshinori Nambu, Hisahide Nishio, Kandai Nozu, and Ryosuke Bo. 2025. "Total Intramuscular Fat Fraction of Thigh Muscles as a Predictor of Nusinersen Efficacy in Pediatric SMA Type II and III" Diagnostics 15, no. 6: 753. https://doi.org/10.3390/diagnostics15060753

APA Style

Iketani, K., Awano, H., Hashimura, H., Sonehara, S., Hanafusa, H., Nambu, Y., Nishio, H., Nozu, K., & Bo, R. (2025). Total Intramuscular Fat Fraction of Thigh Muscles as a Predictor of Nusinersen Efficacy in Pediatric SMA Type II and III. Diagnostics, 15(6), 753. https://doi.org/10.3390/diagnostics15060753

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop